These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 29107111
1. Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1. Huang XP, Li X, Situ MY, Huang LY, Wang JY, He TC, Yan QH, Xie XY, Zhang YJ, Gao YH, Li YH, Rong TH, Wang MR, Cai QQ, Fu JH. Cancer Lett; 2018 Feb 01; 414():294-300. PubMed ID: 29107111 [Abstract] [Full Text] [Related]
2. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma. Liu T, Li R, Zhao H, Deng J, Long Y, Shuai MT, Li Q, Gu H, Chen YQ, Leng AM. Oncotarget; 2016 Oct 11; 7(41):66851-66864. PubMed ID: 27588477 [Abstract] [Full Text] [Related]
3. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway. Li DJ, Shi M, Wang Z. Thorac Cancer; 2016 Sep 11; 7(5):570-580. PubMed ID: 27766776 [Abstract] [Full Text] [Related]
4. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q. PLoS One; 2017 Sep 11; 12(4):e0174276. PubMed ID: 28406985 [Abstract] [Full Text] [Related]
5. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. Wang TH, Wan JY, Gong X, Li HZ, Cheng Y. Oncol Rep; 2012 Nov 11; 28(5):1681-6. PubMed ID: 22941407 [Abstract] [Full Text] [Related]
9. Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma. Xu Y, Zhou L, Huang J, Liu F, Yu J, Zhan Q, Zhang L, Zhao X. Clin Cancer Res; 2011 Aug 15; 17(16):5412-22. PubMed ID: 21676925 [Abstract] [Full Text] [Related]
14. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma. Liu X, Ma W, Yan Y, Wu S. J Biochem Mol Toxicol; 2017 Dec 15; 31(12):. PubMed ID: 28914995 [Abstract] [Full Text] [Related]
18. Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma. Xu J, Hu Z. Biomed Pharmacother; 2016 Apr 15; 79():17-22. PubMed ID: 27044807 [Abstract] [Full Text] [Related]
19. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE2. Pun IH, Chan D, Chan SH, Chung PY, Zhou YY, Law S, Lam AK, Chui CH, Chan AS, Lam KH, Tang JC. Cancer Res Treat; 2017 Jan 15; 49(1):219-229. PubMed ID: 27456944 [Abstract] [Full Text] [Related]
20. Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery. Zhang J, Jiang D, Li X, Lv J, Xie L, Zheng L, Gavine PR, Hu Q, Shi Y, Tan L, Ge D, Xu S, Li L, Zhu L, Hou Y, Wang Q. Lab Invest; 2014 Aug 15; 94(8):917-26. PubMed ID: 24999713 [Abstract] [Full Text] [Related] Page: [Next] [New Search]